0000899243-23-007726.txt : 20230309
0000899243-23-007726.hdr.sgml : 20230309
20230309160018
ACCESSION NUMBER: 0000899243-23-007726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230220
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprague John M
CENTRAL INDEX KEY: 0001730056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 23719597
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-20
0
0001492674
T2 Biosystems, Inc.
TTOO
0001730056
Sprague John M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2023-02-20
4
M
0
4000
A
7047
D
Common Stock
2023-02-22
4
S
0
1545
0.65
D
5502
D
Common Stock
2023-02-24
4
M
0
2914
A
8416
D
Common Stock
2023-02-28
4
S
0
1148
0.59
D
7268
D
Restricted Stock Units
2023-02-20
4
M
0
4000
0.00
D
Common Stock
4000
8000
D
Restricted Stock Units
2023-02-24
4
M
0
2914
0.00
D
Common Stock
2914
2914
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on June 15, 2018.
On February 20, 2022 the reporting person was granted 12,000 RSU's that vest in three equal annual installments commencing on February 20, 2023
On February 24, 2021 the reporting person was granted 8,743 RSU's that vest in three equal annual installments commencing on February 24, 2022.
/s/ John Sprague, Attorney-in-fact
2023-03-09